Lena Moran-Adams

Generell Rådgivare på GUBRA A/S

Health Technology

Consumer Services

Commercial Services

Profil

Lena Moran-Adams is currently Group General Counsel at Gubra A, starting in 2026.
Formerly, Ms. Moran-Adams was Head-Legal & Business Conduct at Gilead Sciences, Inc. from 2019 to 2021, Global Head-Legal at Novartis AG from 2011 to 2019, and General Counsel at Telix Pharmaceuticals Ltd. Education includes graduate studies at Flinders University.

Aktiva positioner av Lena Moran-Adams

Företag	Position	Start
GUBRA A/S	Generell Rådgivare	2026-06-16

Alla aktiva positioner av Lena Moran-Adams

Tidigare kända positioner av Lena Moran-Adams

Företag	Position	Slut
GILEAD SCIENCES, INC.	Generell Rådgivare	2021-07-01
NOVARTIS AG	Generell Rådgivare	2019-01-01
TELIX PHARMACEUTICALS LIMITED	Generell Rådgivare	-

Se detaljerna i Lena Moran-Adamss erfarenhet

Lena Moran-Adamss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Lena Moran-Adamss erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Gilead Sciences, Inc. Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Flinders University Flinders University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Telix Pharmaceuticals Ltd. Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals	Health Technology
Gubra A/S Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company	Commercial Services